Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berlin plans six vast COVID-19 vaccination centres handling 4,000 people a day

Thu, 26th Nov 2020 15:32

By Caroline Copley

BERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass
vaccination centres capable of handling up to 4,000 people per
day by mid-December, the project coordinator told Reuters on
Thursday, as the city waits for authorities to approve the first
vaccines.

An empty trade fair hall, two airport terminals, a concert
arena, a velodrome and an ice rink will be turned into six
vaccination centres where it plans to administer up to 900,000
shots against the coronavirus in the first three months.

Albrecht Broemme said plans envisage 3,000 to 4,000 people
per day being ferried through each centre in the same way as
shoppers are guided through IKEA stores in one direction.

"The biggest challenge will be succeeding in getting the
right people at the right time at the right vaccination centre,"
Broemme said on the sidelines of a fire drill at the city's
makeshift COVID-19 hospital in a trade fair hall.

Germany appears to be the furthest ahead of European nations
in its planning for the daunting logistical and administrative
challenge that could be just a few weeks away if the first
vaccines gain approval.

Europe's drug watchdog expects to receive the first
application for conditional marketing approval for a COVID-19
vaccine "in the coming days", it said on Thursday, the latest
step towards making a shot available outside the United States.

Broemme said Berlin is working on the assumption that around
80% of its doses in the first instance will come from Pfizer
/BioNTech with the remaining 20% of the doses
from AstraZeneca.

Health Minister Jens Spahn said Germany has secured around
300 million vaccine doses. Other German states have said
vaccination centres will be ready from mid-December and mobile
teams will inoculate the most vulnerable.

Elsewhere in Europe, preparations appear mixed.

In Spain, the government aims to vaccinate a substantial
part of its population in the first half of 2021 and has opted
to use trucks rather than centres to distribute the shots.

Italy expects to have vaccinated most Italians by next
September and is due to set out detailed plans on Dec. 2. France
has said it could start administering shots as soon as the end
of the year and will unveil its strategy next week.

Britain plans to roll out vaccines using a mixture of
centres and doctors' practices and is aiming to have enough
shots to have some sort of normality after Easter.

In contrast, Hungary and Bulgaria are not expecting to
receive their first shipments until Spring.

Berlin's vaccination centres will be open seven days a week
and on public holidays from 0900 to 1900, Broemme said, with the
aim of completing the first phase within three months. After
that people will get shots at doctors' practices and pharmacies.

Those aged over 75 and healthcare workers are expected to be
first-in-line, the city's health senator said last week.

One challenge will be finding enough staff to operate the
centres, which will need medical professionals, stewards and
security guards. EasyJet has offered some of its
first-aid trained staff, a spokesman said.

Broemme expects each person to spend around one hour in the
centre. People will be monitored for side effects for around 30
minutes after receiving a shot amid strict social-distancing and
hygiene standards.
(Reporting by Caroline Copley
Additional reporting by Alistair Smout and Sarah Young in
London, Emilio Paradi in Milan, Emma Pinedo Gonzalez in Madrid,
Matthias Blamont in Paris, Krisztina Than in Budapest, Tsvetelia
Tsolova in Sofia)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.